Mdecins Du Monde competitive analysis

Explore patent oppositions filed by Mdecins Du Monde against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 2, 2026
Patent NumberTitleApplicantOpposition Date
Use Of Chimeric Antigen Receptor-Modified T Cells To Treat CancerTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJul 2, 2019

Latest PTAB cases involving Mdecins Du Monde

Discover the latest PTAB cases involving Mdecins Du Monde, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Mdecins Du Monde with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 2, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MDECINS DU MONDE1 - - -
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA - 44 - 7